Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $83.51 in the prior trading day, Haemonetics Corp (NYSE: HAE) closed at $80.67, down -3.40%. In other words, the price has decreased by -$3.40 from its previous closing price. On the day, 0.61 million shares were traded. HAE stock price reached its highest trading level at $83.2 during the session, while it also had its lowest trading level at $80.5.
Ratios:
Our goal is to gain a better understanding of HAE by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 106.96. For the most recent quarter (mrq), Quick Ratio is recorded 2.09 and its Current Ratio is at 3.49. In the meantime, Its Debt-to-Equity ratio is 1.39 whereas as Long-Term Debt/Eq ratio is at 1.39.
On September 13, 2024, CL King started tracking the stock assigning a Buy rating and target price of $116.
On September 11, 2024, BofA Securities started tracking the stock assigning a Neutral rating and target price of $85.BofA Securities initiated its Neutral rating on September 11, 2024, with a $85 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Lingamneni Anila bought 6,238 shares for $90.68 per share.
Strong Stewart W sold 4,312 shares of HAE for $393,039 on Jul 26 ’24. The President, Global Hospital now owns 18,196 shares after completing the transaction at $91.15 per share. On Jul 26 ’24, another insider, Strong Stewart W, who serves as the Officer of the company, bought 4,312 shares for $91.15 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HAE now has a Market Capitalization of 4194194432 and an Enterprise Value of 5066502144. As of this moment, Haemonetics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 33.50, and their Forward P/E ratio for the next fiscal year is 15.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.98 while its Price-to-Book (P/B) ratio in mrq is 4.62. Its current Enterprise Value per Revenue stands at 3.722 whereas that against EBITDA is 16.127.
Stock Price History:
Over the past 52 weeks, HAE has reached a high of $97.97, while it has fallen to a 52-week low of $70.25. The 50-Day Moving Average of the stock is 0.30%, while the 200-Day Moving Average is calculated to be -2.28%.
Shares Statistics:
The stock has traded on average 611.71K shares per day over the past 3-months and 474380 shares per day over the last 10 days, according to various share statistics. A total of 50.38M shares are outstanding, with a floating share count of 49.68M. Insiders hold about 1.09% of the company’s shares, while institutions hold 112.18% stake in the company. Shares short for HAE as of 1731628800 were 4581509 with a Short Ratio of 7.49, compared to 1728950400 on 5262151. Therefore, it implies a Short% of Shares Outstanding of 4581509 and a Short% of Float of 14.42.
